Talphera signals ~$200,000 annual U.S. CRRT procedures in 2027 market sizing as NEPHRO CRRT reaches 75% enrollment

Trial StartNEPHRO CRRTPositive

AI Analysis

Summary

Talphera announced market sizing projections of approximately 200,000 annual U.S. CRRT procedures in 2027, while the NEPHRO CRRT trial has reached 75% enrollment.

Clinical Trial Data

Financial Highlights

Guidance

~$200,000 annual U.S. CRRT procedures projected for 2027

Outcome Details

NEPHRO CRRT trial at 75% enrollment

Importance:5/10

Sentiment:

0.60

clinical trialCRRTmarket sizingenrollment progressnephrology

Related Companies

$TLPH

Read the original article

Published by Seeking Alpha Healthcare on August 13, 2026 8:28 AM

Read Original